Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Acta Clinica Belgica|January 1, 1996
Cytochrome P450: genetic polymorphism and drug interactionsF M Belpaire, M G Bogaert
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1975
Metabolism of papaverine. III. Effect of phenobarbital, 3-methylcholanthrene and SKF 525-A pre-treated in vivo and in vitroF M Belpaire, M G Bogaert
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1975
Metabolism of papaverine. II. Species differencesF M Belpaire, M G Bogaert
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1991
Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serumF M Belpaire, M G Bogaert
Journal of Clinical Pharmacology|April 1, 1990
Binding of diltiazem to albumin, alpha 1-acid glycoprotein and to serum in manF M Belpaire, M G Bogaert
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1987
SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sitesF M Belpaire, B Chindavijak, M G Bogaert
The Journal of Pharmacy and Pharmacology|December 1, 1987
Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liverB Chindavijak, F M Belpaire, M G Bogaert
The Journal of Pharmacy and Pharmacology|November 1, 1987
In-vitro biotransformation of antipyrine, lignocaine and propranolol in the liver of rats with turpentine-induced inflammationB Chindavijak, F M Belpaire, M G Bogaert
European Journal of Clinical Pharmacology|January 1, 1982
Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serumF M Belpaire, M G Bogaert, M Rosseneu
Pageof 16